The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pleural Effusions Treatment Market Research Report 2024
Synopsis
Pleural effusions treatment includes medical procedures and interventions used to manage the accumulation of fluid in the pleural space around the lungs.
The global Pleural Effusions Treatment market was valued at US$ 1522.7 million in 2023 and is anticipated to reach US$ 2474.1 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
The market for pleural effusions treatment is driven by the demand for effective and minimally invasive procedures to drain and manage pleural fluid build-up. The market's growth is also influenced by the increasing prevalence of pleural effusions in various medical conditions, such as congestive heart failure and cancer.
This report aims to provide a comprehensive presentation of the global market for Pleural Effusions Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pleural Effusions Treatment.
Report Scope
The Pleural Effusions Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pleural Effusions Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pleural Effusions Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Nouvag
Oakworks Medical
Heyer Medical
Smith Medical
Biometrix
Maxer
Redax
Bicakcilar
Grena
Shyndec Pharmaceutical
Lepu Medical
Balance Medical
Segment by Type
Thoracentesis
Pleurodesis
Pleuroperitoneal Shunt
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pleural Effusions Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pleural effusions treatment includes medical procedures and interventions used to manage the accumulation of fluid in the pleural space around the lungs.
The global Pleural Effusions Treatment market was valued at US$ 1522.7 million in 2023 and is anticipated to reach US$ 2474.1 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
The market for pleural effusions treatment is driven by the demand for effective and minimally invasive procedures to drain and manage pleural fluid build-up. The market's growth is also influenced by the increasing prevalence of pleural effusions in various medical conditions, such as congestive heart failure and cancer.
This report aims to provide a comprehensive presentation of the global market for Pleural Effusions Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pleural Effusions Treatment.
Report Scope
The Pleural Effusions Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pleural Effusions Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pleural Effusions Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Nouvag
Oakworks Medical
Heyer Medical
Smith Medical
Biometrix
Maxer
Redax
Bicakcilar
Grena
Shyndec Pharmaceutical
Lepu Medical
Balance Medical
Segment by Type
Thoracentesis
Pleurodesis
Pleuroperitoneal Shunt
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pleural Effusions Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pleural Effusions Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Thoracentesis
1.2.3 Pleurodesis
1.2.4 Pleuroperitoneal Shunt
1.3 Market by Application
1.3.1 Global Pleural Effusions Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pleural Effusions Treatment Market Perspective (2019-2030)
2.2 Pleural Effusions Treatment Growth Trends by Region
2.2.1 Global Pleural Effusions Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pleural Effusions Treatment Historic Market Size by Region (2019-2024)
2.2.3 Pleural Effusions Treatment Forecasted Market Size by Region (2025-2030)
2.3 Pleural Effusions Treatment Market Dynamics
2.3.1 Pleural Effusions Treatment Industry Trends
2.3.2 Pleural Effusions Treatment Market Drivers
2.3.3 Pleural Effusions Treatment Market Challenges
2.3.4 Pleural Effusions Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pleural Effusions Treatment Players by Revenue
3.1.1 Global Top Pleural Effusions Treatment Players by Revenue (2019-2024)
3.1.2 Global Pleural Effusions Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Pleural Effusions Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pleural Effusions Treatment Revenue
3.4 Global Pleural Effusions Treatment Market Concentration Ratio
3.4.1 Global Pleural Effusions Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pleural Effusions Treatment Revenue in 2023
3.5 Pleural Effusions Treatment Key Players Head office and Area Served
3.6 Key Players Pleural Effusions Treatment Product Solution and Service
3.7 Date of Enter into Pleural Effusions Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pleural Effusions Treatment Breakdown Data by Type
4.1 Global Pleural Effusions Treatment Historic Market Size by Type (2019-2024)
4.2 Global Pleural Effusions Treatment Forecasted Market Size by Type (2025-2030)
5 Pleural Effusions Treatment Breakdown Data by Application
5.1 Global Pleural Effusions Treatment Historic Market Size by Application (2019-2024)
5.2 Global Pleural Effusions Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pleural Effusions Treatment Market Size (2019-2030)
6.2 North America Pleural Effusions Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pleural Effusions Treatment Market Size by Country (2019-2024)
6.4 North America Pleural Effusions Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pleural Effusions Treatment Market Size (2019-2030)
7.2 Europe Pleural Effusions Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pleural Effusions Treatment Market Size by Country (2019-2024)
7.4 Europe Pleural Effusions Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pleural Effusions Treatment Market Size (2019-2030)
8.2 Asia-Pacific Pleural Effusions Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pleural Effusions Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Pleural Effusions Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pleural Effusions Treatment Market Size (2019-2030)
9.2 Latin America Pleural Effusions Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pleural Effusions Treatment Market Size by Country (2019-2024)
9.4 Latin America Pleural Effusions Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pleural Effusions Treatment Market Size (2019-2030)
10.2 Middle East & Africa Pleural Effusions Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pleural Effusions Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Pleural Effusions Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun
11.1.1 B. Braun Company Detail
11.1.2 B. Braun Business Overview
11.1.3 B. Braun Pleural Effusions Treatment Introduction
11.1.4 B. Braun Revenue in Pleural Effusions Treatment Business (2019-2024)
11.1.5 B. Braun Recent Development
11.2 Nouvag
11.2.1 Nouvag Company Detail
11.2.2 Nouvag Business Overview
11.2.3 Nouvag Pleural Effusions Treatment Introduction
11.2.4 Nouvag Revenue in Pleural Effusions Treatment Business (2019-2024)
11.2.5 Nouvag Recent Development
11.3 Oakworks Medical
11.3.1 Oakworks Medical Company Detail
11.3.2 Oakworks Medical Business Overview
11.3.3 Oakworks Medical Pleural Effusions Treatment Introduction
11.3.4 Oakworks Medical Revenue in Pleural Effusions Treatment Business (2019-2024)
11.3.5 Oakworks Medical Recent Development
11.4 Heyer Medical
11.4.1 Heyer Medical Company Detail
11.4.2 Heyer Medical Business Overview
11.4.3 Heyer Medical Pleural Effusions Treatment Introduction
11.4.4 Heyer Medical Revenue in Pleural Effusions Treatment Business (2019-2024)
11.4.5 Heyer Medical Recent Development
11.5 Smith Medical
11.5.1 Smith Medical Company Detail
11.5.2 Smith Medical Business Overview
11.5.3 Smith Medical Pleural Effusions Treatment Introduction
11.5.4 Smith Medical Revenue in Pleural Effusions Treatment Business (2019-2024)
11.5.5 Smith Medical Recent Development
11.6 Biometrix
11.6.1 Biometrix Company Detail
11.6.2 Biometrix Business Overview
11.6.3 Biometrix Pleural Effusions Treatment Introduction
11.6.4 Biometrix Revenue in Pleural Effusions Treatment Business (2019-2024)
11.6.5 Biometrix Recent Development
11.7 Maxer
11.7.1 Maxer Company Detail
11.7.2 Maxer Business Overview
11.7.3 Maxer Pleural Effusions Treatment Introduction
11.7.4 Maxer Revenue in Pleural Effusions Treatment Business (2019-2024)
11.7.5 Maxer Recent Development
11.8 Redax
11.8.1 Redax Company Detail
11.8.2 Redax Business Overview
11.8.3 Redax Pleural Effusions Treatment Introduction
11.8.4 Redax Revenue in Pleural Effusions Treatment Business (2019-2024)
11.8.5 Redax Recent Development
11.9 Bicakcilar
11.9.1 Bicakcilar Company Detail
11.9.2 Bicakcilar Business Overview
11.9.3 Bicakcilar Pleural Effusions Treatment Introduction
11.9.4 Bicakcilar Revenue in Pleural Effusions Treatment Business (2019-2024)
11.9.5 Bicakcilar Recent Development
11.10 Grena
11.10.1 Grena Company Detail
11.10.2 Grena Business Overview
11.10.3 Grena Pleural Effusions Treatment Introduction
11.10.4 Grena Revenue in Pleural Effusions Treatment Business (2019-2024)
11.10.5 Grena Recent Development
11.11 Shyndec Pharmaceutical
11.11.1 Shyndec Pharmaceutical Company Detail
11.11.2 Shyndec Pharmaceutical Business Overview
11.11.3 Shyndec Pharmaceutical Pleural Effusions Treatment Introduction
11.11.4 Shyndec Pharmaceutical Revenue in Pleural Effusions Treatment Business (2019-2024)
11.11.5 Shyndec Pharmaceutical Recent Development
11.12 Lepu Medical
11.12.1 Lepu Medical Company Detail
11.12.2 Lepu Medical Business Overview
11.12.3 Lepu Medical Pleural Effusions Treatment Introduction
11.12.4 Lepu Medical Revenue in Pleural Effusions Treatment Business (2019-2024)
11.12.5 Lepu Medical Recent Development
11.13 Balance Medical
11.13.1 Balance Medical Company Detail
11.13.2 Balance Medical Business Overview
11.13.3 Balance Medical Pleural Effusions Treatment Introduction
11.13.4 Balance Medical Revenue in Pleural Effusions Treatment Business (2019-2024)
11.13.5 Balance Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
